총 148건 중 148건 출력
, 12/15 페이지
-
111
-
Insights Into Modern Undergraduate Ultrasound Education: Prospective Comparison of Digital and Analog Teaching Resources in a Flipped Classroom Concept - The DIvAN Study
-
Weimer, Johannes M.;
Recker, Florian;
Horn, Leonie;
Kuenzel, Julian;
Dirks, Klaus;
Ille, Carlotta;
Buggenhagen, Holger;
Bö
rner, Norbert;
Weimer, Andreas Michael;
Vieth, Thomas;
Lorenz, Liv;
Rink, Maximilian;
Merkel, Daniel;
Dionysopoulou, Anna;
Ludwig, Michael;
Kloeckner, Roman;
Weinmann-Menke, Julia;
Mü
ller, Lukas;
Rudolf-Frey Teaching Department, University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany;
Department of Obstetrics and Prenatal Medicine, University Hospital Bonn, Bonn, Germany;
Rudolf-Frey Teaching Department, University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany;
Department of Otorhinolaryngology, Head and Neck Surgery, University Hospital Regensburg, Regensburg, Germany;
Medical Clinic II, University Hospital Wü
rzburg, Wü
rzburg, Germany;
Rudolf-Frey Teaching Department, University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany;
Rudolf-Frey Teaching Department, University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany;
Gastroenterological Medical Group Offices, MED Specialist Center Mainz, Mainz, Germany;
Clinic for Trauma and Reconstructive Surgery, University Clinic Heidelberg, Heidleberg, Germany;
Rudolf-Frey Teaching Department, University Medical;
(Ultrasound international open,
v.10,
2024,
)
-
112
-
PTK7 is a positive allosteric modulator of GPR133 signaling in glioblastoma
-
Frenster, Joshua D.;
Erdjument-Bromage, Hediye;
Stephan, Gabriele;
Ravn-Boess, Niklas;
Wang, Shuai;
Liu, Wenke;
Bready, Devin;
Wilcox, Jordan;
Kieslich, Bjö
rn;
Jankovic, Manuel;
Wilde, Caroline;
Horn, Susanne;
Strä
ter, Norbert;
Liebscher, Ines;
Schö
neberg, Torsten;
Fenyo, David;
Neubert, Thomas A.;
Placantonakis, Dimitris G.;
;
(Cell reports,
v.42,
2023,
pp.112679)
-
113
-
PTK7 is a positive allosteric modulator of GPR133 (ADGRD1) signaling in GBM
-
Frenster Joshua D.;
Erdjument-Bromage Hediye;
Liu Wenke;
Stephan Gabriele;
Ravn-Boess Niklas;
Bready Devin;
Wilcox Jordan;
Kieslich Björn;
Jankovic Manuel;
Wilde Caroline;
Horn Susanne;
Sträter Norbert;
Liebscher Ines;
Schöneberg Torsten;
Fenyo David;
Neubert Thomas A.;
Placantonakis Dimitris G.;
;
(,
v.,
2022,
)
-
114
-
Adding Etoposide to R-CHOP (R-CHOEP) Does Not Significantly Increase the Risk of Secondary Neoplasms in Patients with Aggressive B-Cell Lymphoma - Results from Randomized Phase 3 Trials of the German Lymphoma Alliance (GLA)
-
Frontzek, Fabian;
Ziepert, Marita;
Nickelsen, Maike;
Altmann, Bettina;
Glass, Bertram;
Haenel, Mathias;
Truemper, Lorenz;
Held, Gerhard;
Bentz, Martin;
Borchmann, Peter;
Dreyling, Martin;
Viardot, Andreas;
Kroschinsky, Frank P.;
Metzner, Bernd;
Staiger, Annette M.;
Horn, Heike;
Ott, German;
Rosenwald, Andreas;
Loeffler, Markus;
Lenz, Georg;
Schmitz, Norbert;
Departement of Medicine A, University Hospital Mü
nster, Mü
nster, Germany;
Institute for Medical Informatics, Statistics and Epidemiology, University Leipzig, IMISE, Leipzig, Germany;
Onkologie Lerchenfeld, Hamburg, Germany;
Institute for Medical Informatics, Statistics and Epidemiology, University Leipzig, IMISE, Leipzig, Germany;
Clinic for Hematology, Oncology, Tumorimmunology and Palliative Care, Helios Clinic Berlin-Buch, Berlin, Germany;
Department of Internal Medicine III, Klinikum Chemnitz, Chemnitz, Germany;
Hematology and Medical Oncology, Georg August University, Gottingen, Germany;
Department for hematology and oncology, Westpfalz-Klinikum Kaiserslautern, Kaiserslautern, Germany;
Department of Internal Medicine III, Municipal Hospital of Karlsruhe, Karlsruhe, Germany;
German Hodgkin Study Group (GHSG) and Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Dü
sseldorf (CIO ABCD), University of Cologne, Cologne, Germany;
(Blood,
v.136,
2020,
pp.5-6)
-
115
-
Conventional Immunochemotherapy (R-CHOEP) Vs High-Dose Immunochemotherapy (R-MegaCHOEP) in Younger Patients with High-Risk Aggressive B-Cell Lymphoma: 10-Year Long-Term Follow-up of a German Lymphoma Alliance (GLA) Study
-
Frontzek, Fabian;
Ziepert, Marita;
Nickelsen, Maike;
Altmann, Bettina;
Glass, Bertram;
Hä
nel, Mathias;
Truemper, Lorenz;
Held, Gerhard;
Bentz, Martin;
Borchmann, Peter;
Dreyling, Martin H.;
Viardot, Andreas;
Kroschinsky, Frank P.;
Metzner, Bernd;
Staiger, Annette M.;
Horn, Heike;
Ott, German;
Rosenwald, Andreas;
Loeffler, Markus;
Lenz, Georg;
Schmitz, Norbert;
Departement of Medicine A, University Hospital Mü
nster, Mü
nster, Germany;
Institue for Medical Informatics, Statistics and Epidemiology, University Leipzig, IMISE, Leipzig, Germany;
Onkologie Lerchenfeld, Hamburg, Germany;
Institute for Medical Informatics, Statistics and Epidemiology, University Leipzig, IMISE, Leipzig, Germany;
Clinic for Hematology, Oncology, Tumorimmunology and Palliative Care, Helios Clinic Berlin-Buch, Berlin, Germany;
Department of Internal Medicine III, Klinikum Chemnitz, Chemnitz, Germany;
Hematology and Medical Oncology, Georg August University, Gottingen, Germany;
Department of Internal Medicine I, Westpfalz-Klinikum, Kaiserslauern, DEU;
Department of Internal Medicine III, Municipal Hospital of Karlsruhe, Karlsruhe, Germany;
Department of Internal Medicine I, University Hospital Cologne, Cologne, Germany;
Department of Medicine III, University Hospital, LMU Munich, Munich, Germany;
Department of Internal Medicine III, University Hospita;
(Blood,
v.134,
2019,
pp.1589-1589)
-
116
-
Mining the red deer genome (CerEla1.0) to develop X-and Y-chromosome-linked STR markers
-
Frank, Krisztiá
n;
Bana, Nó
ra Á
.;
Bleier, Norbert;
Sugá
r, Lá
szló
;
Nagy, Já
nos;
Wilhelm, Jú
lia;
Ká
lmá
n, Zsó
fia;
Barta, Endre;
Orosz, Lá
szló
;
Horn, Pé
ter;
Sté
ger, Viktor;
Agricultural Biotechnology Institute, National Agricultural Research and Innovation Center, Gö
dö
llő
, Hungary;
Agricultural Biotechnology Institute, National Agricultural Research and Innovation Center, Gö
dö
llő
, Hungary;
Ministry of Agriculture, Department of Wildlife Management, Budapest, Hungary;
Department of Wildlife Biology and Ethology, Faculty of Agricultural and Environmental Sciences, Kaposvá
r University, Kaposvá
r, Hungary;
Game Management Landscape Center, Faculty of Agricultural and Environmental Sciences, Kaposvá
r University, Bő
szé
nfa, Hungary;
Agricultural Biotechnology Institute, National Agricultural Research and Innovation Center, Gö
dö
llő
, Hungary;
Agricultural Biotechnology Institute, National Agricultural Research and Innovation Center, Gö
dö
llő
, Hungary;
Agricultural Biotechnology Institute, National Agricultural Research and Innovation Center, Gö
dö
ll
(PLoS ONE,
v.15,
2020,
pp.e0242506)
-
117
-
High-grade B-cell lymphoma with <i>MYC</i> and <i>BCL2</i> and/or <i>BCL6</i> rearrangements with diffuse large B-cell lymphoma morphology
-
Scott, David W.;
King, Rebecca L.;
Staiger, Annette M.;
Ben-Neriah, Susana;
Jiang, Aixiang;
Horn, Heike;
Mottok, Anja;
Farinha, Pedro;
Slack, Graham W.;
Ennishi, Daisuke;
Schmitz, Norbert;
Pfreundschuh, Michael;
Nowakowski, Grzegorz S.;
Kahl, Brad S.;
Connors, Joseph M.;
Gascoyne, Randy D.;
Ott, German;
Macon, William R.;
Rosenwald, Andreas;
Centre for Lymphoid Cancer, British Columbia Cancer Agency, Vancouver, Canada;
;
Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN;
;
Department of Clinical Pathology, Robert-Bosch-Krankenhaus, Stuttgart, Germany;
;
Centre for Lymphoid Cancer, British Columbia Cancer Agency, Vancouver, Canada;
;
Department of Molecular Biology and Biochemistry, Simon Fraser University, Vancouver, Canada;
;
Dr. Margarete Fischer-Bosch Institute of Clinical Pharmacology, Stuttgart and University of Tuebingen, Tuebingen, Germany;
;
Centre for Lymphoid Cancer, British Columbia Cancer Agency, Vancouver, Canada;
;
Centre for Lymphoid Cancer, British Columbia Cancer Agency, Vancouver, Canada;
;
Centre for Lymphoid Cancer, British Columbia Cancer Agency, Vancouver, Canada;
;
Centre for Lymphoid Cancer, British Columbia Cancer Agency, Vancouver, Canada;
;
Department of Medicine, Hematology and Oncology, University Hospital Muenster, Muenster, Germany;
;
Department of Medicine, Hematolo;
(Blood,
v.131,
2018,
pp.2060-2064)
-
118
-
MYC status in concert with BCL2 and BCL6 expression predicts outcome in diffuse large B-cell lymphoma
-
Horn, Heike;
Ziepert, Marita;
Becher, Claudia;
Barth, Thomas F. E.;
Bernd, Heinz-Wolfram;
Feller, Alfred C.;
Klapper, Wolfram;
Hummel, Michael;
Stein, Harald;
Hansmann, Martin-Leo;
Schmelter, Christopher;
Mö
ller, Peter;
Cogliatti, Sergio;
Pfreundschuh, Michael;
Schmitz, Norbert;
Trü
mper, Lorenz;
Siebert, Reiner;
Loeffler, Markus;
Rosenwald, Andreas;
Ott, German;
Department of Clinical Pathology, Robert-Bosch-Krankenhaus and Dr. Margarete Fischer-Bosch Institute of Clinical Pharmacology, Stuttgart, Germany;
;
Institute for Medical Informatics, Statistics, and Epidemiology, Universitä
t Leipzig, Leipzig, Germany;
;
Institute of Human Genetics, Christian-Albrechts-University Kiel and University Hospital Schleswig-Holstein, Campus Kiel, Kiel, Germany;
;
Institute of Pathology, Universitä
tsklinikum Ulm, Ulm, Germany;
;
Institute of Pathology, Universitä
tsklinikum Schleswig-Holstein, Campus Lü
beck, Lü
beck, Germany;
;
Institute of Pathology, Universitä
tsklinikum Schleswig-Holstein, Campus Lü
beck, Lü
beck, Germany;
;
Institute of Pathology, Hematopathology Section and Lymph Node Registry, Universitä
tsklinikum Schleswig-Holstein, Campus Kiel, Kiel, Germany;
;
Institute of Pathology, Campus Benjamin Franklin, Charité
Universitä
tsmedizin, Berlin, Germany;
;
Institute of Pathology, Campus Benjamin Fra;
(Blood,
v.121,
2013,
pp.2253-2263)
-
119
-
A 70% cut-off for MYC protein expression in diffuse large B-cell lymphoma identifies a high-risk group of patients
-
Ziepert, Marita;
Lazzi, Stefano;
Santi, Raffaella;
Vergoni, Federica;
Granai, Massimo;
Mancini, Virginia;
Staiger, Annette M.;
Horn, Heike;
Lö
ffler, Markus;
Pö
schel, Viola;
Held, Gerhald;
Wulf, Gerald;
Trü
mper, Lorenz H.;
Schmitz, Norbert;
Rosenwald, Andreas;
Sabattini, Elena;
Naresh, Kikkeri N.;
Stein, Harald;
Ott, German;
Leoncini, Lorenzo;
University of Leipzig - Institute of Medical Informatics, Statistics and Epidemiology , Leipzig, Germany;
Department of Medical Biotechnology, Section of Pathology, University of Siena , Siena, Italy;
Department of Pathology, Careggi University Hospital, University of Firenze , Firenze, Italy;
Department of Pathology, Careggi University Hospital, University of Firenze , Firenze, Italy;
Department of Medical Biotechnology, Section of Pathology, University of Siena , Siena, Italy;
Department of Medical Biotechnology, Section of Pathology, University of Siena , Siena, Italy;
Department of Clinical Pathology, Robert- Bosch-Krankenhaus , Stuttgart, Germany;
Department of Clinical Pathology, Robert- Bosch-Krankenhaus , Stuttgart, Germany;
Institute for Medical Informatics Statistics and Epidemiology, University of Leipzig , Leipzig, Germany;
DSHNHL Studiensekretariat, Universitä
tsklinikum des Saarlandes , Homburg;
Germany;
DSHNHL Studiensekretariat, Universitä
tsklinikum d;
(Haematologica,
v.105,
2020,
pp.2667-2670)
-
120
-
<i>TP53</i> mutation and survival in aggressive B cell lymphoma
-
Zenz, Thorsten;
Kreuz, Markus;
Fuge, Maxi;
Klapper, Wolfram;
Horn, Heike;
Staiger, Annette M.;
Winter, Doris;
Helfrich, Hanne;
Huellein, Jennifer;
Hansmann, Martin‐
Leo;
Stein, Harald;
Feller, Alfred;
Mö
ller, Peter;
Schmitz, Norbert;
Trü
mper, Lorenz;
Loeffler, Markus;
Siebert, Reiner;
Rosenwald, Andreas;
Ott, German;
Pfreundschuh, Michael;
Stilgenbauer, Stephan;
Molecular Therapy in Haematology and Oncology and Department of Translational Oncology, National Center for Tumor Diseases (NCT) and German Cancer Research Center (dkfz), Heidelberg, Germany;
Institute for Medical Informatics, Statistics and Epidemiology, Universitä
t Leipzig, Leipzig, Germany;
Dept. of Internal Medicine III, University of Ulm, Ulm, Germany;
Institute of Pathology, Hematopathology Section and Lymph Node Registry, Universitä
tsklinikum Schleswig‐
Holstein, Campus Kiel, Kiel, Germany;
Department of Clinical Pathology, Robert‐
Bosch‐
Krankenhaus, and Dr. Margarete Fischer‐
Bosch‐
Institute of Clinical Pharmacology, and University of Tü
bingen, Stuttgart, Germany;
Department of Clinical Pathology, Robert‐
Bosch‐
Krankenhaus, and;
(International journal of cancer: Journal international du cancer,
v.141,
2017,
pp.1381-1388)